MSD

News

MSD, Moderna skin cancer vaccine scores historic phase 3 win

Strong phase 3 results for Moderna's individualised skin cancer vaccine could pave the way for a leap forward in the field.

News

Trump with the vaccine Order in the Oval Office

Trump order upturns federal childhood vaccines policy

Trump has signed an order that rips up the current US policy on childhood vaccines, demanding changes that experts say will put children at risk.

News

MSD records one hit, one miss with TL1A drug tulisokibart

MSD's tulisokibart was effective in a phase 2 trial in skin disorder hidradenitis suppurativa, but has failed a study in rare lung disorder SSc-ILD.

News

Lawmakers seek answers from RFK on Gardasil shot settlement

Four Democratic senators are investigating whether the family of HHS Secretary RFK Jr is profiting from what they assert are "bogus" vaccine lawsuits.

News

Gilead, MSD share data on once-weekly oral HIV treatment

Gilead/MSD's once-weekly oral medicine for HIV has been shown to achieve high rates of viral suppression in phase 3, setting up regulatory filings.

News

MSD gets first FDA okay for oral PCSK9 cholesterol drug

MSD has won the race to bring an oral PCSK9 inhibitor through to regulatory approval for LDL cholesterol-lowering in the US.

MSD, Moderna skin cancer vaccine scores historic phase 3 win

Trump order upturns federal childhood vaccines policy

MSD records one hit, one miss with TL1A drug tulisokibart

Lawmakers seek answers from RFK on Gardasil shot settlement

Gilead, MSD share data on once-weekly oral HIV treatment

MSD gets first FDA okay for oral PCSK9 cholesterol drug

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

MSD

Editor's Picks